🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We have an opening for a senior bioinformatics experts to work on two exciting projects relating to breast tumor evolution/prevention and ovarian cancer drug resistance. Highly collaborative group. Job ad: shorturl.at/cgjoD. #cancerresearch #Bioinformatics #cancertherapy

Lots of opportunities open for trainees in our lab. Stable funding for the next 3-4 years. Just attaching the tech posting, but look forward to hearing from potential postdoc applicants also. ccf.wd1.myworkdayjobs.com/ClevelandClini…

Duke is a wonderful and supportive place to do science, and the Triangle is a phenomenal place to live. Come join us!

Tenure-track Faculty Position, Cancer Biology job with Duke Pharmacology and Cancer Biology | 12805221 nature.com/naturecareers/…

A cool collaboration between two Wood labs: Kris Wood Kris Wood and Kevin Wood’s teams tackle two long-standing questions: (1) Why do some cancers become “addicted” to the drugs used to treat them, while others don’t, 1/2

Drug dependence in cancer is exploitable by optimally constructed treatment holidays rdcu.be/dsigp

There is not enough space on Twitter to allow me to say all I want, so I’ll keep this brief and expand on it later. First, thank you John Calipari for coming our way in a great time of need in 2009. You performed miracles, NCAA title in 2012. It was a glorious and fun ride.

This was an amazing collaboration with @MartinCNRS and Alex Puissant Lab led by extraordinary students Lois Kelly, Justine Rutter, and Kevin Lin. We hope this is an important step toward the clinic. Congratulations to everyone!

Cool to be fortunate enough to contribute to this awesome npj Journals story from the Kris Wood lab combining ERKi with mediator kinase inhibition in KRAS-mutant cancers. KRASKickers nature.com/articles/s4169…

This one has been a long time coming! Very excited to get this highly collaborative work out. More evidence that considering cell states in conjunction with driver oncogenes needs a close look!

A beautiful note of hope on July 4th!

Welcome, Alicia Darnell and Chris Chidley!

➡️Join us at the next BCDI meeting on FRIDAY July 26th at 3PM on the Harvard Med Quad (Goldenson 122) for an exciting presentation and discussion with Stephen Tait (@MitosRUs) on targeting mitochondria to engage immunogenic cell death. More info: BostonCellDeath.org

News & Views by Aaron Stonestrom and Ross Levine on three recent papers including one from our lab on targeting #PI3Kgamma in #AML. Our paper by Qingyu Luo, MD, PhD; other papers from Kris Wood Kris Wood and Alex Puissant Lab, and Jean Zhao. nature.com/articles/s4301…

After the Minnesota Timberwolves beat the Nuggets last year, Charles Barkley said he hadn't been there in a long time. Ant Edwards famously quipped, "Bring ya ass." The state proclamation to congratulate the team secretly spelled out, "Bring ya ass." It was signed by Tim Walz.

A great opportunity for a postdoc in Israel, with a lucrative fellowship to become a member of the supportive Azrieli community. If you’re looking for a postdoc in cancer genetics, check out our lab at: bendavidlab.com.

I credit this paper by Kevin Wood as the original inspiration for our lab's current work. In person, he was always kind, thoughtful & fun. It's so very sad to lose him this young. Heartfelt condolences to his family & many friends. Descansa en paz, Kevin. pnas.org/doi/full/10.10…

Exciting findings in a study led by Shane Killarney in the Kris Wood lab: Mesenchymal-like cancer cells depend on PKN2 kinase for survival, offering a potential therapeutic target against drug resistance. A cool collaboration with the Pendergast and McDonnell labs ⬇️ Duke Cancer

Thanks, Elizabeth McKenna! It was great working with you and your team Cancer Discovery on this manuscript.

From the March issue: PKN2 Is a Dependency of the Mesenchymal-like Cancer Cell State brnw.ch/21wRxs9 By Shane Killarney, Kris Wood, and colleagues Duke Pharmacology & Cancer Biology Department Duke Cancer